SC 13G/A: Harmony Biosciences Holdings, Inc.
Ticker: HRMY · Form: SC 13G/A · Filed: 2024-02-13T00:00:00.000Z
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by Harmony Biosciences Holdings, Inc..
Risk Assessment
Risk Level: low
From the Filing
0001193125-24-034131.txt : 20240213 0001193125-24-034131.hdr.sgml : 20240213 20240213190651 ACCESSION NUMBER: 0001193125-24-034131 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20240213 DATE AS OF CHANGE: 20240213 GROUP MEMBERS: ANTONIO J. GRACIAS GROUP MEMBERS: JUAN A. SABATER GROUP MEMBERS: VALOR EQUITY ASSOCIATES IV L.P. GROUP MEMBERS: VALOR EQUITY CAPITAL IV LLC GROUP MEMBERS: VALOR EQUITY PARTNERS IV L.P. GROUP MEMBERS: VALOR EQUITY PARTNERS IV-A L.P. GROUP MEMBERS: VALOR EQUITY PARTNERS IV-B L.P. GROUP MEMBERS: VALOR MANAGEMENT L.P. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Harmony Biosciences Holdings, Inc. CENTRAL INDEX KEY: 0001802665 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 822279923 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-91635 FILM NUMBER: 24631013 BUSINESS ADDRESS: STREET 1: 630 W GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 BUSINESS PHONE: (484) 539-9800 MAIL ADDRESS: STREET 1: 630 W GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Valor IV Pharma Holdings, LLC CENTRAL INDEX KEY: 0001821186 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 875 N. MICHIGAN AVENUE STREET 2: SUITE 3214 CITY: CHICAGO STATE: IL ZIP: 60611 BUSINESS PHONE: (312) 568-4766 MAIL ADDRESS: STREET 1: 875 N. MICHIGAN AVENUE STREET 2: SUITE 3214 CITY: CHICAGO STATE: IL ZIP: 60611 SC 13G/A 1 d778408dsc13ga.htm SC 13G/A SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Harmony Biosciences Holdings, Inc (Name of Issuer) Common Stock, $0.00001 par value per share (Title of Class of Securities) 413197 104 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☐ Rule 13d-1(b) ☐ Rule 13d-1(c) ☒ Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 413197 104 13G Page 2 of 12 Pages  1.   NAME OF REPORTING PERSON   Valor IV Pharma Holdings, LLC  2.  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a) ☐  (b) ☐  3.  SEC USE ONLY  4.  CITIZENSHIP OR PLACE OF ORGANIZATION   Delaware NUMBER OF SHARES  BENEFICIALLY  OWNED BY EACH REPORTING PERSON WITH: 5.   SOLE VOTING POWER  — 6.  SHARED VOTING POWER   11,218,033 7.  SOLE DISPOSITIVE POWER  — 8.  SHARED DISPOSITIVE POWER   11,218,033  9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON   11,218,033 10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES  ☐ 11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)   19.2% 12.  TYPE OF REPORTING PERSON   OO CUSIP No. 413197 104 13G Page 3 of 12 Pages  1.   NAME OF REPORTING PERSON  Valor Equity Partners IV L.P.  V